REVUMENIB vs RIBOCICLIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REVUMENIB vs RIBOCICLIB: Safety Overview
| Metric | REVUMENIB | RIBOCICLIB |
|---|---|---|
| Total FAERS Reports | 371 | 27,997 |
| Deaths Reported | 49 | 4,501 |
| Death Rate | 13.2% | 16.1% |
| Hospitalizations | 93 | 6,700 |
| Average Patient Age | 46.4 yrs | 60.2 yrs |
| % Female Patients | 47.6% | 99.0% |
| FDA Approval Date | Nov 15, 2024 | Mar 13, 2017 |
| Manufacturer | Syndax Pharmaceuticals, Inc. | Novartis Pharmaceuticals Corporation |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |